V Trademark

Trademark Overview

On Friday, June 4, 2021, a trademark application was filed for V with the United States Patent and Trademark Office. The USPTO has given the V trademark a serial number of 90755123. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Tuesday, February 18, 2025. This trademark is owned by Verrica Pharmaceuticals Inc.. The V trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Pharmaceutical products and preparations for the treatment of dermatological diseases

Retail services through direct solicitation by distributors directed to end users featuring pharmaceuticals
v

General Information

Serial Number90755123
Word MarkV
Filing DateFriday, June 4, 2021
Status760 - EX PARTE APPEAL PENDING
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Description of MarkThe mark consists of the stylized letter "V". Above the stylized letter "V" are three circles.
Goods and ServicesPharmaceutical products and preparations for the treatment of dermatological diseases
Goods and ServicesRetail services through direct solicitation by distributors directed to end users featuring pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code005
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023
International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code035
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

Trademark Owner History

Party NameVerrica Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380
Party NameVerrica Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380

Trademark Events

Event DateEvent Description
Tuesday, June 8, 2021NEW APPLICATION ENTERED
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 27, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 21, 2022ASSIGNED TO EXAMINER
Friday, February 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 18, 2022SOU TEAS EXTENSION RECEIVED
Friday, November 18, 2022SOU EXTENSION 1 FILED
Friday, November 18, 2022SOU EXTENSION 1 GRANTED
Tuesday, November 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 30, 2023SOU EXTENSION 2 FILED
Tuesday, May 30, 2023SOU EXTENSION 2 GRANTED
Thursday, June 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 13, 2023USE AMENDMENT FILED
Thursday, October 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 13, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, October 26, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 25, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, November 29, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 25, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 1, 2024ASSIGNED TO LIE
Monday, August 26, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 26, 2024SU - FINAL REFUSAL - WRITTEN
Tuesday, November 26, 2024EX PARTE APPEAL-INSTITUTED
Monday, January 27, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, February 18, 2025SU - EXAMINER STATEMENT - WRITTEN
Tuesday, February 18, 2025NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Tuesday, February 18, 2025EXAMINERS STATEMENT E-MAILED
Monday, August 26, 2024FINAL REFUSAL E-MAILED
Tuesday, November 26, 2024EXPARTE APPEAL RECEIVED AT TTAB

Related Keywords

distributors solicitation direct directed users pharmaceuticals featuring through services preparations